MedTrace Logo

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

NCT04019080 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-07-15

No results posted yet for this study

Summary

The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.

Conditions

Interventions

OTHER

Anti-fibrostic drugs

The real-Life use of anti-fibrotic drugs in patients with idiopathic pulmonary fibrosis in Sweden

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04019080 on ClinicalTrials.gov